[1] Dwyer R. The ADVIA Centaur infectious disease assays: a technical review. J Clin Virol,2004,30 Suppl 1:S1-5.
[2] Bosch FX, Ribes J, Cleries R. Epidemiology of hepatocellular carcinoma. Clin Liver Dis, 2005, 9: 191-211.
[3] Craxi A, Marino L, Aragona E, et al. IgM anti-HBc in acute and chronic hepatitis B virus (HBV) infection: diagnostic value and correlation with viral replication and disease activity. Boll lst Sieroter Milan, 1988, 67: 275-282.
[4] Echevarria JM, Leon P, Pozo F. Hepatitis B virus surface antigen reactivity in the absence of antibodies to core antigen: an atypical serological pattern having diverse significance. Enferm Infect Microbiol Clin, 2004, 22:6-12.
[5] Rodella A, Galli C, Terlenyhi L, et al. Quantitative analysis of HBsAg, IgM anti-HBc and anti-HBc avidity in acute and chronic hepatitis B. J Clin Virol, 2006, 37: 206-212.
[6] Park JW, Kwak KM, Kim SE, et al. Differentiation of acute and chronic hepatitis B in IgM anti-HBc positive patients. World J Gastroenterol, 2015, 21: 3953-3959.
[7] Zachoval R, Roggendorf M, Frosner GG, et al. Anti HBc-IgM in acute and chronic hepatitis B. Med Welt, 1981, 32: 93-94.
[8] Chen JJ, Lin CY, Sheu MJ, et al. Poor response to 18-month lamivudine monotherapy in chronic hepatitis B patients with IgM anti-HBc and acute exacerbation. Alimen Pharmacol Ther, 2006, 23: 85-90.
[9] Diment JA. Sensitivity of anti-HBc IgM kits and the diagnosis of acute hepatitis B. J Clin Pathol, 1991, 44: 438.
[10] Delladetsima I, Papatheodoridis GV, Tiniakos DG, et al. Significance of liver histology in HBsAg-positive, IgM anti-HBc-negative acute hepatitis B virus-related hepatitis. Histopathology, 2012, 61: 881-888.
[11] Huang YW, Lin CL, Chen PJ, et al. Higher cut-off index value of immunoglobulin M antibody to hepatitis B core antigen in Taiwanese patients with hepatitis B. JGastroenterol Hepatol, 2006, 21: 859-862. |
